https://sputnikglobe.com/20210619/sputnik-v-developer-assures-that-vaccine-does-not-cause-infertility-1083187643.html
Sputnik V Developer Assures Vaccine Does Not Cause Infertility
Sputnik V Developer Assures Vaccine Does Not Cause Infertility
Sputnik International
MOSCOW (Sputnik) - The Russian coronavirus vaccine Sputnik V does not make people infertile as it is based on adenoviruses, Alexander Gintsburg, the director... 19.06.2021, Sputnik International
2021-06-19T04:40+0000
2021-06-19T04:40+0000
2021-06-19T04:45+0000
https://cdn1.img.sputnikglobe.com/img/07e5/03/01/1082223356_0:67:3119:1830_1920x0_80_0_0_f925c918f02e3487765c5db2a513332e.jpg
russia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
newsfeed, vaccine, vaccine, coronavirus, alexander gintsburg, gamaleya research institute of epidemiology and microbiology, russia
newsfeed, vaccine, vaccine, coronavirus, alexander gintsburg, gamaleya research institute of epidemiology and microbiology, russia
Sputnik V Developer Assures Vaccine Does Not Cause Infertility
04:40 GMT 19.06.2021 (Updated: 04:45 GMT 19.06.2021) MOSCOW (Sputnik) - The Russian coronavirus vaccine Sputnik V does not make people infertile as it is based on adenoviruses, Alexander Gintsburg, the director of Russia's Gamaleya Research Institute of Epidemiology and Microbiology, has told Sputnik.
The scientist noted that the vaccine's two components use adenovirus type 26 and adenovirus type 5, which have been circulating among humans for a very long time.
"Has anyone been made infertile or incapable of other reproductive processes? We have never found it in any medical reports", Gintsburg explained, while also saying that the vaccine does not have negative side effects.
Sputnik V has been approved in 67 countries since the drug's registration last August. According to the latest analysis of data on the post-vaccination infection percentage among 3.8 million vaccinated Russians, the vaccine shows 97.6% efficacy against symptomatic COVID-19 cases.
